institute for health economics and clinical epidemiology chronic illiness and the role of primary...
TRANSCRIPT
Institute for Health Economics and Clinical Epidemiology
Chronic Illiness and the Role of Primary Care in Disease Management in Germany
M. Lüngen, PhD Acting Director
Institute for Health Economics and Clinical Epidemiology
Seite 2
Institute for Health Economics and Clinical Epidemiology
Founded 1996, Institute is part of the University Hospital of Cologne.
About 15 scientists (physicians, economists, statisticians). Research:
Health policy. Cost-effectiveness analysis, financing. Public health, equity in health care.
www.igke.de [email protected]
Institute for Health Economics and Clinical Epidemiology
Seite 3
Characteristics of Primary Care in Germany
Physicians in practices
Physicians in hospitals
Primary carephysicians
Specialists(outpatient care)
Data
: Ger
man
y, y
ear 2
003
118,000
Specialists(inpatient care)
146,00059,000 59,000
Access without referral.Copayment 10 € per visitNearly no gate-keeping functionNo single contractingFee-for-service scheme
Access without referral.Copayment 10 € per visit....................................................................................No single contractingFee-for-service scheme
Access mostly with referral.Copayment 10 € per day..............................................................................................No single contractingDRG scheme
Institute for Health Economics and Clinical Epidemiology
Seite 4
Key elements of the German health care system
Insured/Patient
200 Health Insurance Companies(statutory health insurance only, about 90% of inhabitants)
Pharmacy(Drugs)
Provider
MembershipContribution
• unrestricted access• no preferred provider• gate-keeping only by 10€ fee per visit in 3 month prescription
payment
Nobody really does coordination of care in Germany
Institute for Health Economics and Clinical Epidemiology
Seite 5
Why was Disease Management introduces in Germany?
Problems:
Risk selection between health plans: healthy and wealthy insured were preferred due to incomplete measurement of income and morbidity.
No grouper for morbidity was available for Germany (lack of scientists, research programs, and data).
Competition for quality care for chronic ill was set on the political agenda (not competition for good risks and not competition for efficiency alone).
Institute for Health Economics and Clinical Epidemiology
Seite 6
How was Disease Management introduced in Germany?
Health Insurance Companies(health plans)
Pool of all contributionsDisease-Management Program
InsuredPrimary Care Physicians
Federal Social-Insurance Authority
Contribution
Management
PaymentFor Insured
Quality-Certification
Initiates
Includesinto DMP
Fee-for-Service
Institute for Health Economics and Clinical Epidemiology
Seite 7
Coordination of care in Disease-Management Programs in Germany
Primary Care PhysiciansPatient Health Insurance Companies
(health plans)
Shows diabetes inclusion criteria Includes patient
Pays management fee to physicianGives information to service organisation, EMR
Gets reminder from EMRProvides service Gets quality report
Gets reminder from EMR
No caremanagers
needed
Institute for Health Economics and Clinical Epidemiology
Seite 8
Integrating Disease-Management Programms into the risk-adjustment scheme (Diabetes Type I)
man, 50 y.healthy
Expenditureper year €
marginal expenditure
for diabetes I
Mean of chronic ill diabetes
man, 50 y.healthy
man, 50 y.healthy
man, 50 y.healthy
marginal expenditure
for diabetes care
Redistribution for healthy was reduced.
Redistribution for chronically ill was raised.
Mean of all
insured Mean of „healthy“ insured
before 2002 from 2002
2,000€
4,500€
1,920€
Institute for Health Economics and Clinical Epidemiology
Seite 9
Four diseases were selected first for re-distribution, certification etc.
Diabetes mellitus Type II
Breast Cancer
Asthma/ COPD
Coronary Heart Disease
~ 3,000
No. of programs
2.1 m
No. of patients
+ 1,232 €(=4,600 €)
re-distribution per patient
per year
~ 1,500 74 tsd+ 3,864 €(=6,700 €)
~ 200 80 tsd+ 315 €
(=2,300 €)
~ 800 722 tsd+ 869 €
(=4.600 €)
Data: Germany, year 2006
Institute for Health Economics and Clinical Epidemiology
Seite 10
How was Disease Management introduced in Germany?Quality assurance
Not the health plan, but physicians (both in offices and hospitals) were allowed to include patients into disease management programs.
Physicians get an additional fee for managing patient within disease management, but no pay-for-performance.
The high redistribution per patient and year made high controls for including patients necessary (gaming).
All disease-management programs must be quality-certified by the „Bundesversicherungsamt“ (Federal Social-Insurance Authority).
Institute for Health Economics and Clinical Epidemiology
Seite 11
Evaluation: Is there Evidence?
First full evaluation of 3-year-period will be available in summer 2007.
Today:
1-year-results of several health insurance companies.
Limited data of baseline (clinical parameter).
Some control groups (matching).
Patient surveys of subjective health.
Institute for Health Economics and Clinical Epidemiology
Seite 12
Were Disease-Management Programms effective in Germany?Diabetes Care (BARMER Ersatzkasse)
Data: Diabetes Disease-Management Program, BARMER Ersatzkasse, 587 answers, 1 year after program started
negotiated therapy goals with physicians
got yearly training
got inspection of feet
reported better management
reported better (subjective) health status
64 %
Non-included patients
81 %
Included patients
50% 66 %
64 % 89 %
85 %
15 %
Institute for Health Economics and Clinical Epidemiology
Seite 13
Were Disease-Management Programms effective in Germany?AOK (four regions): Smoking Habits
1. Halbjahr2004
2. Halbjahr2004
2. Halbjahr2003
6,4
12,3
8,5
7,2
7,0
12,6
8,5
17,7
11,8
11,6
9,0
9,5
0 2 4 6 8 10 12 14 16 18 20
Sachsen
Bremen
Mecklenburg-V.
Hessen
Prozent
*Data: 4,800 AOK patients, included in DMP in 06-12/2003
Region
Institute for Health Economics and Clinical Epidemiology
Seite 14
Were Disease-Management Programms effective in Germany?AOK (four regions): HbA1c Clinical Parameter Diabetes
1. Halbjahr2004
2. Halbjahr2004
2. Halbjahr2003
Prozent
*Data: 4,800 AOK patients, included in DMP in 06-12/2003
6,69
7,01
6,98
7,06
6,73
7,11
7,09
7,13
7,15
7,27
7,05
6,88
6,4 6,5 6,6 6,7 6,8 6,9 7 7,1 7,2 7,3 7,4
Sachsen
Bremen
Mecklenburg-V.
Hessen
Region
Institute for Health Economics and Clinical Epidemiology
Seite 15
Were Disease-Management Programms effective in Germany?AOK (four regions): Diabetes Care Blood Pressure (systolic)
1. Halbjahr2004
2. Halbjahr2004
2. Halbjahr2003
Prozent
*Data: 4,800 AOK patients, included in DMP in 06-12/2003
142
143
141
142
142
144
143
151
150
151
141
148
134 136 138 140 142 144 146 148 150 152
Sachsen
Bremen
Mecklenburg-V.
Hessen
Region
Institute for Health Economics and Clinical Epidemiology
Seite 16
Were Disease-Management Programms effective in Germany?AOK (six regions): Eye examinations
%
*Data: AOK patients, reports year 2005
78
92 95
8490
7367
78
32%
32% of diabetes patients got regularly eye examination before introducing disease management programs in Germany.
Region
Institute for Health Economics and Clinical Epidemiology
Seite 17
Were Disease-Management Programms effective in Germany?Region Nordrhein: Diabetes
66% of all insured with Diabetes were included in DMP.
63% of all primary care physician practices are certified and joined the DMP.
Average of 77 diabetes-patients per practice (250.000 patients)
Institute for Health Economics and Clinical Epidemiology
Seite 18
Were Disease-Management Programms effective in Germany?Region Nordrhein: Diabetes; Blood Pressure
Institute for Health Economics and Clinical Epidemiology
Seite 19
Non-included
Included in DMP
Age
Diabetes Mellitus II; Expenditures; Inpatient Care;in € per year
Institute for Health Economics and Clinical Epidemiology
Seite 20
Germany as a solution?
Health plans should not be punished for managing bad risks. Extra payment from the pool for Disease-Management Programs are foreseen in Germany even after using morbidity oriented risk adjustment schemes (inpatient diagnosis, Rx etc.).
Get physicians as partners, not as subordinates in questions of guidelines, therapies, and design of programs.
Quality oriented programs and budget neutrality.
Reduce bureaucracy. Documentation is main reason for low adherence among physicians and patients.
Institute for Health Economics and Clinical Epidemiology
Seite 21
Key messages
Germany has a authority-managed money pool to reward evidence-based, certified Disease-Management Programs.
Because of the financial incentive for including patients into the programs, primary care physicians are important partners of the health plans.
Certified primary care physicians get normal fee plus additional payment for managing the patients. Main organisation workload is done by IT partners.
Evaluations today seems to show an increase in quality and decrease in cost.
1.
2.
3.
4.
Institute for Health Economics and Clinical Epidemiology
Seite 22
Thank you very much for your attention!
Any questions to DMP or health care in [email protected]